Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NOVONIX ADR | GC30 | Nov 25, 2024 | 2.16 | +24.86 |
Novonix Limited | GC3 | Nov 25, 2024 | 0.56 | +25.96 |
NOVOTEK AB B SK-,25 | Z9D | Nov 25, 2024 | 5.82 | 0.00 |
Novozymes AS | NZM | Nov 25, 2024 | 56.50 | +4.63 |
Novozymes B | NZM2 | Nov 25, 2024 | 56.88 | +0.21 |
Novra Technologies Inc. | 7CV | Nov 25, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Nov 25, 2024 | 0.39 | +1.04 |
NOW Inc. | 11N | Nov 25, 2024 | 13.90 | +2.21 |
NP3 Fastigheter | N33 | Nov 25, 2024 | 21.55 | +1.41 |
NPC Inc | 59N | Nov 25, 2024 | 5.80 | +2.65 |
NRC Group | 8NR | Nov 25, 2024 | 0.30 | +5.56 |
NRG Energy Inc. | NRA | Nov 25, 2024 | 90.62 | -1.65 |
NRJ Group | NR8 | Nov 25, 2024 | 6.90 | -1.15 |
NRW Holdings Limited | 3NR | Nov 25, 2024 | 2.30 | -2.54 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Nov 25, 2024 | 26.20 | +3.15 |
NSE SA | 7YM | Nov 25, 2024 | 28.10 | +0.36 |
NSI N.V. | N4RN | Nov 25, 2024 | 19.48 | -0.41 |
NSJ Gold Corp | 9PZ | Nov 25, 2024 | 0.01 | 0.00 |
NSK Ltd. | NSK | Nov 25, 2024 | 4.14 | +0.98 |
NTG Nordic Transport Group | NRSA | Nov 25, 2024 | 38.90 | -0.64 |
NTN Corporation | NTN | Nov 25, 2024 | 1.44 | 0.00 |
NTT Data Corporation | NT5 | Nov 25, 2024 | 18.20 | +2.82 |
NTT DATA GROUP ADR O.N. | NT50 | Nov 25, 2024 | 13.30 | 0.00 |
Nu Holdings Ltd | M1Z | Nov 25, 2024 | 13.15 | -1.51 |
Nu Skin Enterprises, Inc. | NUS | Nov 25, 2024 | 6.90 | -0.72 |
Nubian Resources Ltd | IVHN | Nov 25, 2024 | 0.04 | +61.11 |
Nucleus Financial Group | 0RK | Nov 25, 2024 | 4.34 | 0.00 |
Nucor Corporation | NUO | Nov 25, 2024 | 145.80 | +2.79 |
NuEnergy Gas Limited | NUB | Nov 25, 2024 | 0.00 | -12.50 |
NUERNBERGER Beteiligungs AG | NBG6 | Nov 25, 2024 | 49.80 | -3.30 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.